Avid Bioservices Inc
NASDAQ:CDMO
Avid Bioservices Inc
NASDAQ:CDMO
Price:
8.09 USD
1.76%
Market Closed
Updated:
Jun 1, 2024
Avid Bioservices Inc
Other Current Liabilities
|
Avid Bioservices Inc
Other Current Liabilities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Avid Bioservices Inc
NASDAQ:CDMO
|
Other Current Liabilities
$55.1m
|
CAGR 3-Years
5%
|
CAGR 5-Years
29%
|
CAGR 10-Years
15%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Current Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Current Liabilities
$3.3B
|
CAGR 3-Years
149%
|
CAGR 5-Years
406%
|
CAGR 10-Years
26%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Current Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Current Liabilities
$648.6m
|
CAGR 3-Years
32%
|
CAGR 5-Years
8%
|
CAGR 10-Years
27%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Current Liabilities
$516.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
23%
|
See Also
What is Avid Bioservices Inc's Other Current Liabilities?
Other Current Liabilities
55.1m
USD
55.1m
USD
Based on the financial report for Jan 31, 2024, Avid Bioservices Inc's Other Current Liabilities amounts to 55.1m USD.
What is Avid Bioservices Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
15%
15%
Over the last year, the Other Current Liabilities growth was 41%. The average annual Other Current Liabilities growth rates for Avid Bioservices Inc have been 5% over the past three years , 29% over the past five years , and 15% over the past ten years .
You don't have any saved screeners yet
